InspireMD, Inc.
NSPR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $7 | $6 | $5 | $4 |
| % Growth | 13% | 20% | 15% | – |
| Cost of Goods Sold | $6 | $4 | $4 | $4 |
| Gross Profit | $2 | $2 | $1 | $1 |
| % Margin | 21.5% | 29.1% | 21.6% | 16.8% |
| R&D Expenses | $14 | $8 | $8 | $5 |
| G&A Expenses | $15 | $11 | $8 | $7 |
| SG&A Expenses | $21 | $15 | $12 | $10 |
| Sales & Mktg Exp. | $6 | $4 | $4 | $3 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $35 | $23 | $20 | $15 |
| Operating Income | -$34 | -$21 | -$19 | -$15 |
| % Margin | -478% | -340.7% | -361.9% | -327.4% |
| Other Income/Exp. Net | $2 | $1 | $0 | -$0 |
| Pre-Tax Income | -$32 | -$20 | -$18 | -$15 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$32 | -$20 | -$18 | -$15 |
| % Margin | -456.6% | -321% | -357.6% | -331.9% |
| EPS | -0.76 | -0.82 | -2.35 | -2.03 |
| % Growth | 7.3% | 65.1% | -15.8% | – |
| EPS Diluted | -0.76 | -0.82 | -2.35 | -2.03 |
| Weighted Avg Shares Out | 42 | 24 | 8 | 7 |
| Weighted Avg Shares Out Dil | 42 | 24 | 8 | 7 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $1 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$33 | -$21 | -$19 | -$15 |
| % Margin | -474% | -337% | -358.2% | -323.8% |